2023 Guidance
Adjusted net service revenue is anticipated to be in the range of $2.244 billion to $2.274 billion.
Adjusted EBITDA is anticipated to be in the range of $230 million to $240 million.
Adjusted diluted earnings per share is anticipated to be in the range of $4.13 to $4.36 based on an estimated 32.9 million shares outstanding.
This guidance excludes the effects of any future acquisitions and potential share repurchases, if any are made.
Personal Care Divestiture
On February 10, 2023, we signed a definitive agreement to sell our personal care line of business (excluding the Florida operations). The divestment is expected to close during the second quarter of 2023.
BlueCross BlueShield of Tennessee Palliative Care Partnership
We also announced a new agreement between Contessa Health Management, LLC, an Amedisys subsidiary, and BlueCross BlueShield of Tennessee to provide members in Middle Tennessee with palliative care in the comfort of their home.
https://finance.yahoo.com/news/amedisys-reports-fourth-quarter-end-211000824.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.